Cervical cancer
Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
Where to go
3 hospitals in India taking patients for this trial.
Registry summary (technical)
Cervical cancer (CC) remains one of the most common malignancies among women in India, with nearly 100,000 women diagnosed annually and over 60,000 preventable deaths annually. With high-risk human papillomavirus (HR-HPV) as the causative agent for CC, one risk factor that places women at high risk for CC is human immunodeficiency virus (HIV), as impaired immune response against Human papillomavirus (HPV) may result in persistent HR-HPV infection, a critical risk factor for progression of HPV-related cervical oncogenesis. Progression of precancerous lesions among women living with HIV (WLH) is…
Sponsor: University of California, Irvine
NCT07209917 on ClinicalTrials.gov
Last updated on the registry 31 Jul 2026 · read by us 20 Oct 2026